Sidenius N - Search Results

1

The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection.

Alfano M, Sidenius N, Blasi F, Poli G. Alfano M, et al. Among authors: sidenius n. J Leukoc Biol. 2003 Nov;74(5):750-6. doi: 10.1189/jlb.0403176. Epub 2003 Aug 21. J Leukoc Biol. 2003. PMID: 12960238 Review.

2

Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.

Sidenius N, Andolfo A, Fesce R, Blasi F. Sidenius N, et al. J Biol Chem. 2002 Aug 2;277(31):27982-90. doi: 10.1074/jbc.M111736200. Epub 2002 May 28. J Biol Chem. 2002. PMID: 12034711 Free article.

3

Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.

Alfano M, Sidenius N, Panzeri B, Blasi F, Poli G. Alfano M, et al. Among authors: sidenius n. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8862-7. doi: 10.1073/pnas.142078099. Proc Natl Acad Sci U S A. 2002. PMID: 12084931 Free PMC article.

4

Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor.

Andolfo A, English WR, Resnati M, Murphy G, Blasi F, Sidenius N. Andolfo A, et al. Among authors: sidenius n. Thromb Haemost. 2002 Aug;88(2):298-306. Thromb Haemost. 2002. PMID: 12195704

5

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

Sidenius N, Blasi F. Sidenius N, et al. Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):205-22. doi: 10.1023/a:1023099415940. Cancer Metastasis Rev. 2003. PMID: 12784997 Review.

6

The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.

Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N. Cinque P, et al. Among authors: sidenius n. Ann Neurol. 2004 May;55(5):687-94. doi: 10.1002/ana.20076. Ann Neurol. 2004. PMID: 15122709

7

Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease.

Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P. Sidenius N, et al. J Neuroimmunol. 2004 Dec;157(1-2):133-9. doi: 10.1016/j.jneuroim.2004.08.038. J Neuroimmunol. 2004. PMID: 15579290

8

Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion.

Elia C, Cassol E, Sidenius N, Blasi F, Castagna A, Poli G, Alfano M. Elia C, et al. Among authors: sidenius n. J Leukoc Biol. 2007 Nov;82(5):1212-20. doi: 10.1189/jlb.0407251. Epub 2007 Aug 17. J Leukoc Biol. 2007. PMID: 17704294

9

The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling.

Blasi F, Sidenius N. Blasi F, et al. Among authors: sidenius n. FEBS Lett. 2010 May 3;584(9):1923-30. doi: 10.1016/j.febslet.2009.12.039. Epub 2009 Dec 27. FEBS Lett. 2010. PMID: 20036661 Free article. Review.

10

Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance.

Sier CF, Sidenius N, Mariani A, Aletti G, Agape V, Ferrari A, Casetta G, Stephens RW, Brünner N, Blasi F. Sier CF, et al. Among authors: sidenius n. Lab Invest. 1999 Jun;79(6):717-22. Lab Invest. 1999. PMID: 10378514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters